Mektovi (binimetinib) is a prescription drug that’s used to treat certain types of cancer. Mektovi can cause side effects that range from mild to serious. Examples include nausea, diarrhea, and vomiting.
Of Interest
UC San Diego Health first in region to provide novel therapy for melanoma
UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma. The personalized cellular therapy derived from tumor infiltrating lymphocytes (TIL), is the first solid tumor therapy on the market approved by the U.S. Food and Drug Administration (FDA).
New Data With RP1 Plus Nivolumab in PD-1–Refractory Melanoma Build on Positive Findings
The oncolytic immunotherapy RP1 in combination with nivolumab (Opdivo) displayed activity in patients with melanoma who failed prior anti–PD-1 treatment, according to updated findings from the phase 2 IGNYTE trial (NCT03767348).
Researchers discover new therapeutic target for the treatment of melanoma resistant to targeted therapies
An international research team led by scientists from the University of Liège has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies.